Maternal Outcome with Discontinuation of Magnesium Sulfate immediately Postpartum in Severe Preeclampsia
Imam Bano, Pramod R Gade, Yasir Alvi
Citation Information :
Bano I, Gade PR, Alvi Y. Maternal Outcome with Discontinuation of Magnesium Sulfate immediately Postpartum in Severe Preeclampsia. J South Asian Feder Obs Gynae 2017; 9 (2):84-87.
[71-OR]: The revised 2013 ACOG definitions of hypertensive disorders of pregnancy significantly increase the diagnostic prevalence of preeclampsia. Pregnancy Hypertens 2015 Jan;5(1):38.
“Hypertensive disorders.” Williams’ obstetrics. 24th ed. New York, NY: McGraw-Hill Education; 2014. p. 728.
Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulfate? The Magpie Trial: a randomized placebo controlled trial. Lancet 2002 Jun;359(9321):1877-1890.
Shortened postpartum magnesium sulfate treatment for severe preeclampsia. Thai J Obstet Gynaecol 2010 Apr;18(2):63-69.
Magnesium sulfate therapy in eclampsia: the Sokoto (ultra short) regimen. BMC Res Notes 2009 Jan;2(1):165.
Abbreviated (12 hours) versus traditional (24-hours) postpartum magnesium sulfate therapy in severe pre-eclampsia. Int J Gynaecol Obstet 2014 Sep;126(3):260-264.
Maternal outcomes after 12 hours and 24 hours of magnesium sulfate therapy for eclampsia. Int J Gynecol Obstet 2016 Jan;132(1):68-71.
Prophylactic magnesium sulphate in severe preeclampsia-loading dose only vs. Conventional 24 hours therapy of modified Pritchard's regime – a randomised trial. IOSR J Pharm 2014 Jun;4(6):39-47.
